与SVR后肝细胞癌相关的长非编码RNA PWRN4:全基因组关联研究研究
Goki Suda1, Masaya Sugiyama2, Hayato Hikita3
1Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060-8638, Hokkaido, Japan. gsudgast@pop.med.hokudai.ac.jp.
Biomarker research
|September 24, 2025
概括
一项全基因组研究确定了一个基因变异,rs4778350在PWRN4附近,与型肝炎病毒 (HCV) 根除后的肝细胞癌 (HCC) 风险有关. 这种变异增强了基因表达,促进了癌细胞的生长.
科学领域:
- 遗传学 是一个遗传学.
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
背景情况:
- 肝细胞癌 (HCC) 即使在成功根除C型肝炎病毒 (HCV) 后也可能发生.
- 影响HCC发育的宿主遗传因素在HCV治愈后仍然不完全理解.
研究的目的:
- 通过全基因组关联研究 (GWAS) 来确定与HCC根除后HCC发展相关的宿主遗传因素.
- 调查已识别的遗传变异在肝癌发生中的功能作用.
主要方法:
- 在日本患者中进行了两阶段的GWAS,包括HCV根除后的HCC患者和没有HCC患者.
- 利用临床数据和体外细胞测试来评估候选基因变异的影响.
- 进行了多变量分析,以确定HCC的独立风险因素.
主要成果:
- 确定了位于长非编码RNA PWRN4附近的基因变异rs4778350与HCV根除后的HCC发展 (OR=5.86) 之间存在显著的关联.
- rs4778350的AA基因型与增加的HCC风险有关,而女性性别,高血小板计数和高血清白蛋白具有保护作用.
- 实验室研究表明rs4778350AA基因型增强了PWRN4表达,促进了癌细胞的增殖,迁移和入侵.
结论:
- 在PWRN4附近的基因变异rs4778350是HCV根除后HCC发展的重要风险因素.
- 受到rs4778350影响的PWRN4表达,在肝癌发生过程中发挥作用.
- 这些发现提供了个性化风险评估的见解,以及HCV根除患者中HCC的潜在治疗目标.
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs
3.5K
3.5K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Non-LTR Retrotransposons
13.2K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.2K
piRNA - Piwi-interacting RNAs
7.5K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
